Elopag 25 mg (Eltrombopag) is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia and severe aplastic anemia. It stimulates platelet production in the bone marrow. Common side effects include nausea, fatigue, headache, and liver enzyme abnormalities. Regular monitoring is recommended during treatment. https://oncomedicure.com/product/elopag-25-mg-eltrombopag/